BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19751975)

  • 1. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.
    Innocenti A; Pastorekova S; Pastorek J; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5825-8. PubMed ID: 19751975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.
    Winum JY; Innocenti A; Vullo D; Montero JL; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5082-5. PubMed ID: 19632111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
    Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
    Ozensoy Guler O; Arslan O; Kockar F
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
    Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
    Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
    Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S
    J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly.
    Klier M; Jamali S; Ames S; Schneider HP; Becker HM; Deitmer JW
    FEBS J; 2016 Jan; 283(1):191-200. PubMed ID: 26470855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes.
    Hilvo M; Baranauskiene L; Salzano AM; Scaloni A; Matulis D; Innocenti A; Scozzafava A; Monti SM; Di Fiore A; De Simone G; Lindfors M; Jänis J; Valjakka J; Pastoreková S; Pastorek J; Kulomaa MS; Nordlund HR; Supuran CT; Parkkila S
    J Biol Chem; 2008 Oct; 283(41):27799-27809. PubMed ID: 18703501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isoforms I and II and transmembrane, tumor-associated isoforms IX and XII with boronic acids.
    Winum JY; Innocenti A; Scozzafava A; Montero JL; Supuran CT
    Bioorg Med Chem; 2009 May; 17(10):3649-52. PubMed ID: 19375921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase activators: activation of human isozymes I, II and IX with phenylsulfonylhydrazido l-histidine derivatives.
    Abdo MR; Vullo D; Saada MC; Montero JL; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2009 May; 19(9):2440-3. PubMed ID: 19345095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT; Winum JY
    Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
    FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(3):567-71. PubMed ID: 15664814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines.
    Pastorekova S; Vullo D; Nishimori I; Scozzafava A; Pastorek J; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3530-6. PubMed ID: 18294854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site.
    Singh S; Lomelino CL; Mboge MY; Frost SC; McKenna R
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29710858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.